Aurobindo Pharma Limited (BOM:524804)
India flag India · Delayed Price · Currency is INR
1,166.30
+9.20 (0.80%)
At close: Mar 27, 2025

Aurobindo Pharma Statistics

Total Valuation

BOM:524804 has a market cap or net worth of INR 658.72 billion. The enterprise value is 674.37 billion.

Market Cap 658.72B
Enterprise Value 674.37B

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date May 28, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.48%
Shares Change (QoQ) -0.50%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 272.89M

Valuation Ratios

The trailing PE ratio is 18.87.

PE Ratio 18.87
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 2.45
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 19.32
EV / Sales 2.18
EV / EBITDA 10.18
EV / EBIT 13.49
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.27
Debt / EBITDA 1.27
Debt / FCF n/a
Interest Coverage 12.22

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 8.45%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 11.89M
Profits Per Employee 1.34M
Employee Count 26,015
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +7.05% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +7.05%
50-Day Moving Average 1,145.93
200-Day Moving Average 1,313.08
Relative Strength Index (RSI) 47.80
Average Volume (20 Days) 17,187

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:524804 had revenue of INR 309.22 billion and earned 34.91 billion in profits. Earnings per share was 59.81.

Revenue 309.22B
Gross Profit 178.80B
Operating Income 50.11B
Pretax Income 49.61B
Net Income 34.91B
EBITDA 65.72B
EBIT 50.11B
Earnings Per Share (EPS) 59.81
Full Income Statement

Balance Sheet

The company has 68.68 billion in cash and 84.27 billion in debt, giving a net cash position of -15.59 billion.

Cash & Cash Equivalents 68.68B
Total Debt 84.27B
Net Cash -15.59B
Net Cash Per Share n/a
Equity (Book Value) 308.85B
Book Value Per Share 528.88
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 57.82%, with operating and profit margins of 16.21% and 11.29%.

Gross Margin 57.82%
Operating Margin 16.21%
Pretax Margin 16.04%
Profit Margin 11.29%
EBITDA Margin 21.25%
EBIT Margin 16.21%
FCF Margin n/a

Dividends & Yields

BOM:524804 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.48%
Shareholder Yield 0.48%
Earnings Yield 5.30%
FCF Yield n/a
Dividend Details

Stock Splits

The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.

Last Split Date Jul 20, 2015
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a